GlassScriptPhysician profile
Douglas J Pravda
NPI 1427020718
$1,465.92
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $416 · 2021: $594.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $245.02 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $223.12 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $179.98 | 2021 | |
| Pfizer INC. | $135.17 | 2019-2021 | |
| Lilly USA, LLC | $90.59 | 2019-2021 | |
| Genzyme Corporation | $84.20 | 2020-2021 | |
| Galderma Laboratories, L.P. | $74.94 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.09 | 2019-2021 | |
| Janssen Biotech, INC. | $63.62 | 2019-2021 | |
| Vyne Pharmaceuticals INC. | $50.03 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $43.82 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $28.74 | 2020 | |
| Abbvie INC. | $25.88 | 2019-2021 | |
| Incyte Corporation | $22.62 | 2021 | |
| Strata Skin Sciences, INC. | $20.48 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novum Pharma, LLC | $19.07 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.78 | 2021 | |
| Merck Sharp & Dohme LLC | $14.58 | 2019 | |
| Almirall LLC | $13.88 | 2020 | |
| Epi Health, LLC | $13.32 | 2021 | |
| Mission Pharmacal Company | $12.94 | 2021 | |
| Genentech USA, INC. | $12.92 | 2019 | |
| Dusa Pharmaceuticals, INC. | $12.13 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Pravda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.